ConductScience.org, home

Paper42864263PubMed

Gut microbiota shaping fatty liver disease progression.

Wysokińska M and 3 others. Life Sci Alliance, 2027.

Cite this record

ConductScience Library. Gut microbiota shaping fatty liver disease progression. Papers, record 42864263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42864263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gut microbiota shaping fatty liver disease progression.
Journal
Life Sci Alliance
Year
2027
Publication types
Journal Article, Review
Revised in PubMed
2026-10-15

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wysokińska MMartynahttps://orcid.org/0009-0009-6184-2272
2Mysza MMartahttps://orcid.org/0009-0002-6116-3623
3Uryga AEAleksandra Ehttps://orcid.org/0009-0004-6668-2646
4Kołodziejczyk AAAleksandra Ahttps://orcid.org/0000-0002-2903-8884

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal MicrobiomeMajor topic
Fatty LiverMajor topic
Humans
Animals
Disease Progression
Liver
Intestinal Barrier Function
Methylamines
Lipid Metabolism
Bacteria
Bile Acids and Salts
Fatty Acids, Volatile

Source PubMed

Download CSV of topics

References297

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
141087898Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome.BMC Microbiol2025https://conductscience.org/library/papers/41087898PubMed
233894425Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis.Cell Mol Gastroenterol Hepatol2021https://conductscience.org/library/papers/33894425PubMed
322666356Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia.PLoS One2012https://conductscience.org/library/papers/22666356PubMed
428467925Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.Cell Metab2017https://conductscience.org/library/papers/28467925PubMed
522993202Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.Gut2013https://conductscience.org/library/papers/22993202PubMed
624278294Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon.PLoS One2013https://conductscience.org/library/papers/24278294PubMed
724458110Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release.Digestion2014https://conductscience.org/library/papers/24458110PubMed
838298161Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease.Gut Microbes2024https://conductscience.org/library/papers/38298161PubMed
939746606Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease.Mol Metab2025https://conductscience.org/library/papers/39746606PubMed
1040055450Physical activity, diet, and social determinants of health associate with health related quality of life and fibrosis in MASLD.Sci Rep2025https://conductscience.org/library/papers/40055450PubMed
1137364790A multisociety Delphi consensus statement on new fatty liver disease nomenclature.J Hepatol2023https://conductscience.org/library/papers/37364790PubMed
1216453106Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.Cell Tissue Res2006https://conductscience.org/library/papers/16453106PubMed
1319359436Toll-like receptors as targets in chronic liver diseases.Gut2009https://conductscience.org/library/papers/19359436PubMed
1438967596Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment.Hepatol Commun2024https://conductscience.org/library/papers/38967596PubMed
1529563342Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.JCI Insight2018https://conductscience.org/library/papers/29563342PubMed
1638992851Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunction.Pharmacol Res2024https://conductscience.org/library/papers/38992851PubMed
1730120222Microbial tryptophan catabolites in health and disease.Nat Commun2018https://conductscience.org/library/papers/30120222PubMed
1834002097UCP1 governs liver extracellular succinate and inflammatory pathogenesis.Nat Metab2021https://conductscience.org/library/papers/34002097PubMed
1928550049Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease.Gut2018https://conductscience.org/library/papers/28550049PubMed
2027041637CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells.Cell Mol Immunol2017https://conductscience.org/library/papers/27041637PubMed

See all 297 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42864263

GET https://conductscience.org/api/papers/v1/42864263/references?page=2